Genfit
GNFT.PA
| Exchange: | PA |
| Currency | Euro |
| ISIN: | FR0004163111 |
| Primary Ticker: | GNFT.PA |
| Fiscal Year End: | December |
| IPO Date: | 2006-12-19 |
| International Domestic: | International |
| Sector: | Healthcare |
| Industry: | Biotechnology |
| Gic Sector: | Health Care |
| Gic Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| Gic Industry: | Life Sciences Tools & Services |
| Gic Sub Industry: | Life Sciences Tools & Services |
| Description: | Genfit S.A., a late-stage biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company develops Elafibranor, which is in Phase III clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagnosis of nonalcoholic steatohepatitis (NASH) and fibrosis; VS-01 for the treatment of Urea Cycle Disorder (UCD) and Organic Acidemia Disorder (OAD); GNS561, which is in Phase 1b/2a trial to treat patients with cholangiocarcinoma (CCA); VS-01-ACLF and Nitazoxanide (NTZ), which is in Phase 1 trial to treat acute-on-chronic liver failure, as well as VS-02-HE, which is in preclinical trial for the treatment of Reduction of Hyperammonemia and the Stabilization of Blood Ammonia; CML-022; SRT-015, an ASK1 inhibitor targets the inhibition of cellular apoptosis, inflammation, and fibrosis. The company has a licensing agreement with Labcorp for the commercialization of NAS Hnext, a blood-based molecular diagnostic test; and Genoscience Pharma to develop and commercialize the investigational treatment GNS561 for CCA. The company was incorporated in 1999 and is headquartered in Loos, France. |
| Address: | Parc Eurasant E, Loos, France, 59120 |
| Website: | https://www.genfit.com |
| Full Time Employees: | 169 |
| Updated On: | 2024-11-04 |
Highlights
| Market Capitalization: | 272988544 |
| Market Capitalization Mln: | 272.98 |
| EBITDA: | 21857000 |
| PE Ratio: | 14.78 |
| Wall Street Target Price: | 9.3 |
| Book Value: | 1.95 |
| Earnings Share: | 0.37 |
| Most Recent Quarter: | 2024-06-30 |
| Profit Margin: | 0.27 |
| Operating Margin TTM: | 0.51 |
| Return On Assets TTM: | 0.06 |
| Return On Equity TTM: | 0.25 |
| Revenue TTM: | 80474000 |
| Revenue Per Share TTM: | 1.61 |
| Quarterly Revenue Growth YOY: | 3.04 |
| Gross Profit TTM: | 26246000 |
| Diluted Eps TTM: | 0.37 |
Valuation
| Trailing PE: | 14.78 |
| Forward PE: | 7.54 |
| Price Sales TTM: | 3.39 |
| Price Book MRQ: | 2.76 |
| Enterprise Value: | 275654008 |
| Enterprise Value Revenue: | 3.62 |
| Enterprise Value Ebitda: | 9.62 |
Shares
| Shares Outstanding: | 49906500 |
| Shares Float: | 41868648 |
| Percent Insiders: | 13.26 |
| Percent Institutions: | 1.09 |
Technicals
| Beta: | 1.09 |
| 52 Week High: | 5.86 |
| 52 Week Low: | 2.9 |
| 50 Day MA: | 4.63 |
| 200 Day MA: | 3.92 |
Splits & Dividends
| Last Split Factor: | 1739:1687 |
| Last Split Date: | 2016-10-12 |
Earnings
| Report Date: | 2025-04-02 |
| Date: | 2025-03-31 |
| Before After Market: | After Market |
| Currency: | EUR |
| Report Date: | 2023-11-09 |
| Date: | 2023-09-30 |
| Before After Market: | After Market |
| Currency: | EUR |
| Report Date: | 2023-09-20 |
| Date: | 2023-06-30 |
| Before After Market: | After Market |
| Currency: | EUR |
| Eps Estimate: | -0.24 |
| Eps Difference: | 0.24 |
| Surprise Percent: | 10 |
| Report Date: | 2023-05-11 |
| Date: | 2023-03-31 |
| Before After Market: | After Market |
| Currency: | EUR |
| Eps Actual: | -0.48 |
| Eps Estimate: | 0.36 |
| Eps Difference: | -0.84 |
| Surprise Percent: | -233.33 |
| Report Date: | 2023-02-07 |
| Date: | 2022-12-31 |
| Currency: | EUR |
| Eps Estimate: | -0.83 |
| Eps Difference: | 0.83 |
| Surprise Percent: | 10 |
| Report Date: | 2022-11-10 |
| Date: | 2022-09-30 |
| Before After Market: | After Market |
| Currency: | EUR |
| Report Date: | 2022-09-28 |
| Date: | 2022-06-30 |
| Before After Market: | After Market |
| Currency: | EUR |
| Eps Actual: | -0.21 |
| Eps Estimate: | -0.23 |
| Eps Difference: | 0.02 |
| Surprise Percent: | 8.69 |
| Report Date: | 2022-05-11 |
| Date: | 2022-03-31 |
| Before After Market: | After Market |
| Currency: | EUR |
| Eps Actual: | 0.94 |
| Eps Estimate: | -0.79 |
| Eps Difference: | 1.73 |
| Surprise Percent: | 218.98 |
| Report Date: | 2021-11-08 |
| Date: | 2021-09-30 |
| Currency: | EUR |
| Report Date: | 2021-09-29 |
| Date: | 2021-06-30 |
| Before After Market: | After Market |
| Currency: | EUR |
| Eps Actual: | 0.21 |
| Report Date: | 2021-05-12 |
| Date: | 2021-03-31 |
| Before After Market: | After Market |
| Currency: | EUR |
| Eps Actual: | -1.24 |
| Eps Estimate: | -0.86 |
| Eps Difference: | -0.38 |
| Surprise Percent: | -44.18 |
| Report Date: | 2020-11-16 |
| Date: | 2020-09-30 |
| Before After Market: | Before Market |
| Currency: | EUR |
| Eps Estimate: | -0.25 |
| Eps Difference: | 0.25 |
| Surprise Percent: | 10 |
| Report Date: | 2020-09-30 |
| Date: | 2020-06-30 |
| Before After Market: | After Market |
| Currency: | EUR |
| Eps Actual: | -0.38 |
| Eps Estimate: | -1.44 |
| Eps Difference: | 1.06 |
| Surprise Percent: | 73.61 |
| Report Date: | 2020-05-18 |
| Date: | 2020-03-31 |
| Before After Market: | After Market |
| Currency: | EUR |
| Eps Actual: | -0.6 |
| Eps Estimate: | -0.8 |
| Eps Difference: | 0.2 |
| Surprise Percent: | 2 |
| Report Date: | 2019-10-01 |
| Date: | 2019-09-30 |
| Currency: | EUR |
| Eps Actual: | -0.7 |
| Eps Estimate: | -0.75 |
| Eps Difference: | 0.05 |
| Surprise Percent: | 6.66 |
| Report Date: | 2019-09-30 |
| Date: | 2019-06-30 |
| Before After Market: | After Market |
| Currency: | EUR |
| Eps Actual: | -1.64 |
| Eps Estimate: | -0.74 |
| Eps Difference: | -0.9 |
| Surprise Percent: | -121.62 |
| Report Date: | 2019-04-30 |
| Date: | 2019-03-31 |
| Before After Market: | After Market |
| Currency: | EUR |
| Eps Actual: | -0.65 |
| Eps Estimate: | -0.65 |
| Eps Difference: | -0.00 |
| Surprise Percent: | -0.76 |
| Report Date: | 2019-02-05 |
| Date: | 2018-12-31 |
| Before After Market: | Before Market |
| Currency: | EUR |
| Eps Actual: | -1.16 |
| Eps Estimate: | -1.06 |
| Eps Difference: | -0.1 |
| Surprise Percent: | -9.43 |
| Report Date: | 2018-10-23 |
| Date: | 2018-09-30 |
| Before After Market: | Before Market |
| Currency: | EUR |
| Report Date: | 2018-09-24 |
| Date: | 2018-06-30 |
| Before After Market: | After Market |
| Currency: | EUR |
| Eps Actual: | -1.11 |
| Eps Difference: | -1.11 |
| Report Date: | 2018-04-27 |
| Date: | 2018-03-31 |
| Before After Market: | After Market |
| Currency: | EUR |
| Report Date: | 2018-03-13 |
| Date: | 2017-12-31 |
| Before After Market: | After Market |
| Currency: | EUR |
| Eps Actual: | -1.15 |
| Eps Estimate: | -0.92 |
| Eps Difference: | -0.23 |
| Surprise Percent: | -2 |
| Report Date: | 2017-09-25 |
| Date: | 2017-06-30 |
| Before After Market: | After Market |
| Currency: | EUR |
| Eps Actual: | -0.73 |
| Eps Difference: | -0.73 |
| Date: | 2020-12-31 |
| Period: | +1y |
| Revenue Estimate Avg: | 9489740.00 |
| Revenue Estimate Low: | 8200000.00 |
| Revenue Estimate High: | 10400000.00 |
| Revenue Estimate Number Of Analysts: | 2.00 |
| Revenue Estimate Growth: | -0.79 |
| Eps Trend7days Ago: | -2.27 |
| Eps Trend30days Ago: | -2.27 |
| Eps Trend60days Ago: | -2.27 |
| Eps Trend90days Ago: | -2.27 |
| Date: | 2019-12-31 |
| Revenue Estimate Avg: | 46306000.00 |
| Revenue Estimate Low: | 8650000.00 |
| Revenue Estimate High: | 12420000.00 |
| Revenue Estimate Number Of Analysts: | 2.00 |
| Eps Trend7days Ago: | -2.92 |
| Eps Trend30days Ago: | -2.92 |
| Eps Trend60days Ago: | -2.92 |
| Eps Trend90days Ago: | -2.92 |
| Date: | 2019-09-30 |
| Period: | +1q |
| Date: | 2019-06-30 |
| Revenue Estimate Avg: | 6361280.00 |
| Revenue Estimate Low: | 6020000.00 |
| Revenue Estimate High: | 6020000.00 |
| Revenue Estimate Number Of Analysts: | 1.00 |
| Eps Trend7days Ago: | -1.13 |
| Eps Trend30days Ago: | -1.13 |
| Eps Trend60days Ago: | -1.13 |
| Eps Trend90days Ago: | -1.13 |
| Date: | 2016-12-31 |
| Period: | +1y |
| Revenue Estimate Avg: | 6783000.00 |
| Revenue Estimate High: | 14800000.00 |
| Revenue Estimate Number Of Analysts: | 6.00 |
| Revenue Estimate Growth: | 0.55 |
| Eps Trend7days Ago: | -1.34 |
| Eps Trend30days Ago: | -1.34 |
| Eps Trend60days Ago: | -1.34 |
| Eps Trend90days Ago: | -1.34 |
| Date: | 2016-03-31 |
| Period: | +1q |
| Date: | 2015-12-31 |
| Revenue Estimate Avg: | 4358000.00 |
| Revenue Estimate Low: | 2000000.00 |
| Revenue Estimate High: | 60000000.00 |
| Revenue Estimate Number Of Analysts: | 3.00 |
| Revenue Estimate Growth: | -0.35 |
| Eps Trend7days Ago: | -0.70 |
| Eps Trend30days Ago: | -0.70 |
| Eps Trend60days Ago: | -0.70 |
| Eps Trend90days Ago: | -0.70 |
| Date: | 2023-09-30 |
| Eps Actual: | -0.4 |
| Date: | 2022-12-31 |
| Eps Actual: | -4.27 |
| Date: | 2018-12-31 |
| Eps Actual: | -2.2 |
| Date: | 2017-12-31 |
| Eps Actual: | -1.8 |